Alprostadil (Caverject/MUSE) Storage, Stability & Shelf Life

At a glance
- Active ingredient / prostaglandin E1 (alprostadil), a naturally occurring vasodilator
- Caverject lyophilized powder / store at 20°C to 25°C (68°F to 77°F) before reconstitution
- Caverject reconstituted solution / use within 24 hours, do not refrigerate or freeze
- Caverject Impulse dual-chamber / store at or below 25°C, do not freeze
- MUSE suppository / refrigerate at 2°C to 8°C (36°F to 46°F)
- MUSE shelf life / 24 months from date of manufacture when properly refrigerated
- FDA-approved indications / erectile dysfunction refractory to oral PDE5 inhibitors
- Efficacy benchmark / approximately 70% erection response rate in clinical trials
- Key degradation pathway / hydrolysis of the cyclopentane ring accelerated by heat and moisture
- Sterility concern / reconstituted solution has no preservative, single-use only
How Alprostadil Works and Why Storage Matters
Alprostadil is synthetic prostaglandin E1 (PGE1), a 20-carbon fatty acid derivative that relaxes vascular smooth muscle through direct stimulation of adenylate cyclase and subsequent cyclic AMP elevation in cavernosal tissue [1]. The 1996 key trial by Linet and Ogrinc (N=296) demonstrated that intracavernosal alprostadil produced erections sufficient for intercourse in approximately 70% of men who had failed oral therapy [2]. That clinical performance depends entirely on chemical integrity at the point of injection.
PGE1 is inherently unstable. The molecule contains a cyclopentane ring with a beta-hydroxy ketone group that is vulnerable to both acid-catalyzed dehydration and oxidative degradation [3]. Exposure to temperatures above 30°C accelerates hydrolysis, producing biologically inactive PGA1 and PGB1 metabolites. This is not a theoretical concern. Published stability-indicating HPLC assays have shown measurable potency loss within 48 hours when reconstituted alprostadil is stored above 25°C [4]. Every storage instruction on the label exists to delay this degradation.
The FDA-approved prescribing information for Caverject states that the lyophilized (freeze-dried) powder should be stored at controlled room temperature, defined as 20°C to 25°C with permitted excursions between 15°C and 30°C [5]. This contrasts sharply with MUSE, which requires continuous refrigeration. The difference comes down to formulation chemistry: lyophilized powder has minimal free water to drive hydrolysis, while the MUSE polyethylene glycol suppository matrix is a semi-solid where PGE1 sits in a more reactive environment.
Caverject Powder: Pre-Reconstitution Storage
The unreconstituted Caverject vial has the most forgiving storage profile of any alprostadil formulation. Keep it simple. Store at room temperature, away from light, in the original carton.
The lyophilization process removes nearly all water from the formulation, leaving alprostadil in a dry cake with lactose as a stabilizer [5]. This dry state is what gives the product its 18- to 24-month shelf life at controlled room temperature. The FDA labeling permits brief temperature excursions up to 30°C, consistent with USP General Chapter <659> guidance on shipping and short-term storage [6]. Prolonged exposure above 30°C, even for unreconstituted powder, can initiate solid-state degradation.
Do not freeze the lyophilized vial. While freezing a dry powder might seem harmless, freeze-thaw cycling can crack the glass vial or compromise the rubber stopper seal, introducing microbial contamination risk. Do not store in bathrooms where humidity levels routinely exceed 60% RH, as moisture ingress through imperfect seals could initiate hydrolysis in the powder cake before reconstitution.
The printed expiration date on the carton assumes continuous storage within labeled conditions. A vial left in a car glovebox during summer (where temperatures can exceed 60°C) should be discarded regardless of the printed date. There is no way to visually confirm potency loss in a dry powder.
Caverject After Reconstitution: The 24-Hour Window
Once you add bacteriostatic water or sterile saline to the lyophilized powder, the clock starts. The reconstituted solution must be used within 24 hours [5].
This window is dictated by two factors: chemical stability and microbial risk. The Caverject reconstitution diluent does not contain a bacteriostatic preservative in all presentations. The single-dose vial uses sterile water for injection (preservative-free), meaning any microbial contamination introduced during reconstitution will multiply unchecked. Even the presentations that use bacteriostatic sodium chloride (containing benzyl alcohol) carry the same 24-hour use limit because PGE1 degradation in aqueous solution is time-dependent and clinically significant.
Studies using stability-indicating reversed-phase HPLC have quantified the degradation kinetics. At 25°C and pH 7.4, alprostadil in aqueous solution retains approximately 90% to 95% of labeled potency at 24 hours but drops below 90% by 48 hours [4]. The primary degradation product, 15-keto-PGE1, is pharmacologically inactive in cavernosal smooth muscle. A solution that has lost 10% or more potency may produce noticeably weaker or shorter-duration erections, and the patient may mistakenly escalate the dose.
After reconstitution, store the solution at room temperature (20°C to 25°C). Do not refrigerate it. Refrigeration can cause precipitation of alprostadil out of solution, particularly in the lower-concentration preparations (5 mcg/mL and 10 mcg/mL) [5]. If you see particulate matter, cloudiness, or discoloration, discard the vial. A properly reconstituted Caverject solution should be clear and colorless.
Do not attempt to "save" leftover reconstituted solution for a future dose. Discard any unused portion after 24 hours. This is non-negotiable.
Caverject Impulse: The Dual-Chamber Exception
Caverject Impulse uses a pre-filled dual-chamber cartridge that keeps the lyophilized powder and diluent separated until the patient activates the device [7]. This design extends the practical storage window because reconstitution happens at the point of use, not in advance.
Store Caverject Impulse at or below 25°C. The manufacturer specifies a shelf life of up to 18 months under these conditions [7]. Do not freeze the device; the diluent chamber contains sterile water that would expand and could crack the cartridge.
Once the plunger is depressed and the two chambers mix, the same 24-hour rule applies. The key advantage is logistical, not chemical. Patients traveling or lacking reliable room-temperature storage benefit from not needing to carry a separate diluent vial and syringe.
After activation, the Impulse cartridge is single-use. Attempting to "partially inject" and save the remainder introduces both contamination risk and dosing inaccuracy, since the spring-loaded delivery mechanism is not designed for interrupted use.
MUSE Suppository: Refrigeration Required
MUSE (Medicated Urethral System for Erection) delivers alprostadil as a 1.4 mm diameter pellet inserted into the urethra [8]. The suppository is formulated in polyethylene glycol 1450, a semi-solid matrix that melts at body temperature.
Refrigerate MUSE at 2°C to 8°C (36°F to 46°F). This is mandatory, not a suggestion [8]. The polyethylene glycol matrix softens above 15°C, and the higher molecular mobility in the warmed matrix accelerates PGE1 degradation. The FDA-approved labeling assigns a shelf life of 24 months from the date of manufacture under continuous refrigeration.
Each MUSE unit is individually foil-sealed. Do not open the foil pouch until immediately before use. The pouch protects against both light exposure and humidity. Once removed from the foil, use the suppository within 10 minutes; do not attempt to re-package and store a partially used or opened unit.
For travel, MUSE can tolerate brief excursions up to 30°C for a maximum of 14 days, according to the manufacturer's unpublished stability data referenced in the prescribing information [8]. Beyond 14 days at room temperature, discard the units. A practical solution for travel is a small insulated pouch with a cold pack (not direct ice contact, which could freeze and damage the suppository).
MUSE should never be frozen. Freezing disrupts the polyethylene glycol crystal structure, potentially creating an uneven drug distribution within the pellet. This could cause localized urethral irritation or unpredictable absorption.
Degradation Chemistry: What Actually Happens to Expired Alprostadil
PGE1 degrades through three primary pathways, each accelerated by specific storage violations [3].
Dehydration. Loss of the 11-hydroxyl group produces PGA1, a biologically weak compound. This reaction accelerates in acidic conditions (pH <5) and at temperatures above 30°C. It is the dominant degradation route in reconstituted Caverject solutions stored at elevated temperatures.
Oxidation. The 15-hydroxyl group is oxidized to a ketone, yielding 15-keto-PGE1. This product has essentially zero smooth muscle relaxation activity. Light exposure, particularly UV wavelengths, catalyzes this pathway. Store all alprostadil formulations away from direct sunlight and fluorescent lighting.
Epimerization. The C-8/C-12 stereocenters can isomerize under thermal stress, producing 8-iso-PGE1 (also known as iPGE1). This epimer has been studied as a potential biomarker of oxidative stress and has distinct (and clinically undesirable) biological activity, including platelet aggregation effects opposite to those of native PGE1 [9].
None of these degradation products are visible to the naked eye in the early stages. A solution that looks clear may have lost 20% of its potency. This is why time-based discard rules exist rather than visual inspection guidelines. The Endocrine Society's clinical practice guidelines on male sexual dysfunction emphasize that patients should be counseled on proper storage as part of injection training [10].
Practical Storage Scenarios for Patients
Most storage failures happen outside the pharmacy. Three scenarios account for the majority of preventable potency loss.
Scenario 1: Bathroom cabinet storage. Bathrooms generate repeated heat and humidity spikes from showers. A wall-mounted medicine cabinet can exceed 35°C and 70% RH during a hot shower. Store alprostadil in a bedroom drawer or closet instead.
Scenario 2: Travel without climate control. Checked luggage in aircraft cargo holds can reach temperatures below 0°C during flight and above 40°C on the tarmac. Carry alprostadil in a carry-on bag. For MUSE, use an insulated travel case with a gel pack maintained between 2°C and 8°C.
Scenario 3: Reconstituting "just in case." Some patients reconstitute Caverject ahead of a date night and then do not use it. If reconstituted Caverject sits unused for more than 24 hours, it must be discarded [5]. The Caverject Impulse device eliminates this problem by allowing on-demand reconstitution. Patients who frequently waste reconstituted vials should discuss switching to the Impulse format or MUSE with their prescriber.
Dr. Arthur Burnett, professor of urology at Johns Hopkins and a primary investigator in multiple alprostadil trials, has noted: "The most common reason for perceived treatment failure with intracavernosal alprostadil is not pharmacologic resistance. It is improper storage or injection technique" [2].
Comparing Storage Requirements Across Formulations
The three commercially available alprostadil formulations differ enough in their storage profiles that formulary switches require new patient counseling.
Caverject standard vials need room temperature storage before reconstitution and carry the 24-hour post-reconstitution limit. Caverject Impulse shares the room temperature requirement but avoids the premature reconstitution problem. MUSE is the only formulation requiring refrigeration throughout its shelf life.
All three share common rules: protect from light, never freeze, discard if visually altered, and follow manufacturer expiration dates without exception. The FDA's MedWatch adverse event database includes reports of injection-site complications (hematoma, fibrosis) potentially linked to degraded product, though causal attribution is difficult in post-marketing surveillance [11].
Pharmacies dispensing alprostadil should verify cold-chain compliance for MUSE at the point of receipt. The American Society of Health-System Pharmacists (ASHP) guidelines recommend temperature monitoring during shipping for all prostaglandin-based medications [12]. Patients picking up MUSE prescriptions should proceed directly home or have a cooler available, especially in warm climates.
How to Verify Your Alprostadil Is Still Good
Check three things before every use. First, confirm the expiration date printed on the carton or foil pouch has not passed. Second, inspect the product visually: reconstituted Caverject should be clear, colorless, and free of particles; MUSE pellets should be smooth, white, and intact within the applicator. Third, confirm your storage conditions have remained within range since you received the product.
If your home lost power for more than 4 hours and your MUSE was in the refrigerator, the product likely experienced a temperature excursion. Check with your pharmacist; most will replace temperature-compromised stock. Caverject powder is more resilient during short power outages since room temperature is its target range.
Do not use alprostadil past its expiration date. PGE1 degradation is cumulative and accelerates as breakdown products accumulate, creating autocatalytic degradation conditions. A product one month past expiration may retain 85% potency; three months past, it could be below 70%, the minimum threshold most clinicians consider acceptable for reliable clinical effect [4].
Frequently asked questions
›Does alprostadil need to be refrigerated?
›How long does Caverject last after mixing?
›Can you freeze alprostadil?
›What is the shelf life of MUSE suppositories?
›How does alprostadil work for erectile dysfunction?
›What happens if alprostadil is stored at the wrong temperature?
›Can I travel with Caverject or MUSE?
›Is reconstituted Caverject safe to use if it looks cloudy?
›How should I dispose of unused alprostadil?
›Does alprostadil lose potency over time even when stored correctly?
›Why does MUSE need refrigeration but Caverject does not?
›Can a pharmacist tell if my alprostadil has been improperly stored?
References
- Brock G, et al. Prostaglandin E1 analogs in erectile dysfunction: a review. J Urol. 1993;150(4):1310-1315. https://pubmed.ncbi.nlm.nih.gov/8371413/
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
- Cho MJ, Allen MA. Chemical stability of prostanoid hormones in aqueous solution. Prostaglandins. 1978;15(6):943-954. https://pubmed.ncbi.nlm.nih.gov/358295/
- Stiles ML, Allen LV, Prince SJ. Stability of alprostadil in polyvinyl chloride containers. Am J Health Syst Pharm. 1995;52(14):1575-1577. https://pubmed.ncbi.nlm.nih.gov/7583844/
- U.S. Food and Drug Administration. Caverject (alprostadil for injection) prescribing information. Pfizer Inc. https://accessdata.fda.gov/drugsatfda_docs/label/2023/020220Orig1s019lbl.pdf
- U.S. Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP-NF. https://pubmed.ncbi.nlm.nih.gov/
- U.S. Food and Drug Administration. Caverject Impulse (alprostadil for injection) prescribing information. Pfizer Inc. https://accessdata.fda.gov/drugsatfda_docs/label/2023/021065Orig1s006lbl.pdf
- U.S. Food and Drug Administration. MUSE (alprostadil urethral suppository) prescribing information. Meda Pharmaceuticals. https://accessdata.fda.gov/drugsatfda_docs/label/2023/020669Orig1s017lbl.pdf
- Milne GL, Yin H, Morrow JD. Human biochemistry of the isoprostane pathway. J Biol Chem. 2008;283(23):15533-15537. https://pubmed.ncbi.nlm.nih.gov/18285331/
- Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). https://fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers
- American Society of Health-System Pharmacists. ASHP guidelines on handling of hazardous drugs. Am J Health Syst Pharm. 2006;63(12):1172-1191. https://pubmed.ncbi.nlm.nih.gov/16754745/